Dextropropoxyphene withdrawn from the market
Hallelujah! But how many died for nothing? All this time without reacting.
1982: Review Prescribing - anorectite necrotizing (to guess) and life-threatening poisoning
1993: reducing the dose of dextropropoxyphene in the assumed
1996: Prescribing Review - hypoglycemia
1999: Prescribing Review - interactions with carbamazepine (Tegretol ®)
2000: Prescribing Review - unfavorable risk-benefit ("It is not reasonable to take these risks to patients to gain analgesic uncertain")
2001: Pharmacovigilance - hepatic
2003: Removing the Swiss market
2004: Pharmacovigilance - esophageal ulcers
2005: Removing UK market - removal of the Swedish market
2005: 7 deaths reported in France - over 2000 in the USA between 1981 and 1999 (excluding suicide)
2007: Removing the list of authorized products CHU Toulouse
2009: Phasing out of market Europe.
0 comments:
Post a Comment